首页> 外文期刊>Vascular medicine >Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV).
【24h】

Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV).

机译:高结扎和大隐静脉剥离术(GSV)患者的术后静脉血栓栓塞(VTE)预防。

获取原文
获取原文并翻译 | 示例
           

摘要

To analyze the necessity of venous thromboembolism (VTE) prophylaxis for patients undergoing high ligation and stripping of the great saphenous vein (GSV) and to estimate the efficacy and safety of different anticoagulant protocols in a single-center randomized controlled trial with large sample size. A total of 2196 patients undergoing high ligation and stripping of the GSV were randomized to one of the following postoperative VTE prophylaxis protocols: group A, no VTE prophylaxis (n=542); group B, subcutaneous low-dose unfractionated heparin (LDUH) hypodermic injection, 125 U/kg per day in three divided doses (n=531); group C, low-molecular-weight heparin (LMWH) 6000 IU once a day (n=573); and group D, LMWH 4000 IU twice daily (n=550). Groups were compared for the incidence of VTE and major hemorrhage within 1 month following surgery. Varicose vein severity was classified by CEAP (Clinical, Etiologic, Anatomic, Pathophysiologic elements) score. The clinical characteristics of the patients were equally matched between groups. Postoperative deep vein thrombosis (DVT) and pulmonary embolism (PE) were significantly higher in group A (DVT 5.17%, PE 1.48%) compared to groups B (0.56%, 0%), C (0.35%, 0%) and D (0.36%, 0%) (p<0.01). The incidence of VTE did not differ between the three active chemoprophylaxis arms. Hemorrhagic complications were low for each group but higher in group B (0.75%) compared to the other groups (group A 0.18%; group C 0.17%; group D 0.18%, p<0.01). Hemorrhagic complications did not differ amongst groups A, C and D. In conclusion, postoperative VTE chemoprophylaxis following high ligation and GSV stripping effectively reduces the venous thrombosis complications of this procedure. Of the three active strategies tested, no difference in efficacy was noted; however, thrice daily LDUH did increase bleeding complications.
机译:分析接受高结扎和大隐静脉剥离术(GSV)的患者预防静脉血栓栓塞(VTE)的必要性,并在单中心,大样本量的随机对照试验中评估不同抗凝方案的疗效和安全性。总共2196例接受高结扎和剥离GSV的患者被随机分配至以下术后VTE预防方案之一:A组,无VTE预防(n = 542); B组皮下注射低剂量普通肝素(LDUH),每天125 U / kg,分三批(n = 531); C组,低分子量肝素(LMWH)每天6000 IU(n = 573); D组,LMWH 4000 IU,每天两次(n = 550)。比较各组术后1个月内VTE的发生率和主要出血情况。静脉曲张严重程度通过CEAP(临床,病因,解剖,病理生理因素)评分进行分类。两组患者的临床特征均相等。与B组(0.56%,0%),C(0.35%,0%)和D组相比,A组(DVT 5.17%,PE 1.48%)的术后深静脉血栓形成(DVT)和肺栓塞(PE)显着更高(0.36%,0%)(p <0.01)。在三个主动化学预防组之间,VTE的发生率没有差异。与其他各组相比,各组的出血并发症均较低,但B组(0.75%)较高(A组为0.18%; C组为0.17%; D组为0.18%,p <0.01)。 A,C和D组的出血并发症没有差异。总而言之,高结扎和GSV剥离后的术后VTE化学预防有效地减少了该过程的静脉血栓并发症。在测试的三种主动策略中,没有发现疗效差异。但是,每天三次LDUH确实会增加出血并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号